Estrogenic activity of tamoxifen on normal mammary parenchyma in the luteal phase of the menstrual cycle

International Journal of Gynecology and Obstetrics

Volumn 56, Issue 1, 1997, Pages 19-24

  Facina, G ^a,b   Rodrigues De Lima, G ^a   Simoes M J ^a   Novo, N F ^a   Gebrim, L H ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Breast; Luteal phase; Lysosomes; Premenopausal state; Tamoxifen

Indexed keywords

ACID PHOSPHATASE; TAMOXIFEN; TECNOTAX; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST EPITHELIUM; BREAST FIBROADENOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LUTEAL PHASE; LYSOSOME; MENSTRUAL CYCLE; MICROSCOPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

EID: 0031033602     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(96)02791-9     Document Type: Article

References (16)

1. [1] Micaela M, Buckley T, Goa KL. Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. Drugs 1989; 37: 451-490.
2. [2] Martins NV. Quantitative variations of lysosomes in the human endometrial epithelium during the proliferative and secretory phases of the menstrual cycle. Master's thesis, Escola Paulista de Medicina. 1974.
3. [3] De Duve C. Lysosomes revisited. Eur J Biochem 1983; 137: 391-397.
4. [4] Freitas V, Pardi PC, Baracat EC, Rodrigues de Lima G, Simões MJ, Binvignat O. Variacion cuantitativa de los lisosomas en el epitelio de la trompa uterina humana en los periodos menstruales y en la postmenopausia (Quantitative variation of lysosomes in the epithelium of the human uterine tubes during the menstrual period and during menopause). Rev Chil Obstet Ginecol 1991; 56: 359-363.
5. [5] Girão MJBC, Baracat EC, Rodrigues de Lima G, Binuignat O, Simões MJ. Quantitative determination study of lysosomes in the human breast, in the proliferative and secretory phases of the menstrual cycle. Rev Chil Obstet Ginecol 1991; 56: 107-110.
6. [6] Tanaka CI. Quantitative analysis of lysosomes in the breast epithelium during the proliferative and secretory phases of the menstrual cycle during the administration of tamoxifen. Master's thesis, Escola Paulista de Medicina. 1994.
7. [7] Israel R, Mishel JR, Stone SC, Thorneycroft IH, Meyer DL. Single luteal phase serum progesterone assay as an indicator of ovulation. Am J Obstet Gynecol 1972; 112: 1043-1046.
8. [8] Masson P. Tumeurs humaines. Histologie. Diagnostics et techniques (Human tumors. Hystology, diagnosis and techniques). 2nd ed. Paris: Libraire Maloine. 1956; 106-148.
9. [9] Gomori G. Microscopic histochemistry: principles and practice. Chicago: University of Chicago Press. 1952; 137-221.
10. [10] Siegel S. Estadistica no paramétrica aplicada a las ciencias de la conducta (Non-parametric statistics applied to the behavioral sciences). 2nd ed. Mexico: Trillas. 1975; 346.
11. [11] Jordan VC, Fritz NF, Langan-Fahey S, Thompson M, Tormey DC. Alteration of endocrine parameters in pre-menopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent. J Natl Cancer Inst 1991; 83: 1488-1491.
12. [12] Groom GV, Griffiths K. Effect of antioestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women. J Endocrinol 1976; 70: 421-428.
13. [13] Walker KJ, Price-Thomas JM, Candlish W, Nicholson RI. Influence of the antioestrogen tamoxifen on normal breast tissue. Br J Cancer 1991; 64: 764-768.
14. [14] Ruiz-Velasco V, Rosas-Arceo J, Matute MM. Chemical inducers of ovulation: comparative results. Int J Fertil 1979; 24: 61.
15. [15] Gerhard I, Runnebaum B. Comparison between tamoxifen and clomiphene therapy in women with anovulation. Arch Gynecol 1979; 227: 229.
16. [16] Tajima C. Luteotropic effects of tamoxifen in infertile women. Fertil Steril 1984; 42: 223.